| NQ2 | 表記: | ~{N}-[2-methoxy-5-[7-[2-[4-(2-oxidanylpropan-2-yl)piperidin-1-yl]ethoxy]-1,3-dihydro-2-benzofuran-5-yl]pyridin-3-yl]methanesulfonamide | 組成式: | C25 H35 N3 O6 S | SMILES: | COc1ncc(cc1N[S](C)(=O)=O)c2cc3COCc3c(OCCN4CCC(CC4)C(C)(C)O)c2 | InChi: | InChI=1S/C25H35N3O6S/c1-25(2,29)20-5-7-28(8-6-20)9-10-34-23-13-17(11-19-15-33-16-21(19)23)18-12-22(27-35(4,30)31)24(32-3)26-14-18/h11-14,20,27,29H,5-10,15-16H2,1-4H3 | 定義日: | 2019-12-10 | 最終更新日: | 2019-12-27 | 公開日: | 2020-01-01 | 識別子(ID): | ~{N}-[2-methoxy-5-[7-[2-[4-(2-oxidanylpropan-2-yl)piperidin-1-yl]ethoxy]-1,3-dihydro-2-benzofuran-5-yl]pyridin-3-yl]methanesulfonamide |
|
| NQ5 | 表記: | 2-methoxy-~{N}-[2-methoxy-5-[7-[[(2~{R})-4-(oxetan-3-yl)morpholin-2-yl]methoxy]-1,3-dihydro-2-benzofuran-5-yl]pyridin-3-yl]ethanesulfonamide | 組成式: | C25 H33 N3 O8 S | SMILES: | COCC[S](=O)(=O)Nc1cc(cnc1OC)c2cc3COCc3c(OC[CH]4CN(CCO4)C5COC5)c2 | InChi: | InChI=1S/C25H33N3O8S/c1-31-5-6-37(29,30)27-23-8-18(10-26-25(23)32-2)17-7-19-12-33-16-22(19)24(9-17)36-15-21-11-28(3-4-35-21)20-13-34-14-20/h7-10,20-21,27H,3-6,11-16H2,1-2H3/t21-/m1/s1 | 定義日: | 2019-12-11 | 最終更新日: | 2019-12-27 | 公開日: | 2020-01-01 | 識別子(ID): | 2-methoxy-~{N}-[2-methoxy-5-[7-[[(2~{R})-4-(oxetan-3-yl)morpholin-2-yl]methoxy]-1,3-dihydro-2-benzofuran-5-yl]pyridin-3-yl]ethanesulfonamide |
|
| NRZ | 表記: | (2~{S})-~{N}-(3,5-dimethylphenyl)-1-(4-methoxyphenyl)sulfonyl-pyrrolidine-2-carboxamide | 組成式: | C20 H24 N2 O4 S | SMILES: | COc1ccc(cc1)[S](=O)(=O)N2CCC[CH]2C(=O)Nc3cc(C)cc(C)c3 | InChi: | InChI=1S/C20H24N2O4S/c1-14-11-15(2)13-16(12-14)21-20(23)19-5-4-10-22(19)27(24,25)18-8-6-17(26-3)7-9-18/h6-9,11-13,19H,4-5,10H2,1-3H3,(H,21,23)/t19-/m0/s1 | 定義日: | 2019-12-12 | 最終更新日: | 2019-12-27 | 公開日: | 2020-01-01 | 識別子(ID): | (2~{S})-~{N}-(3,5-dimethylphenyl)-1-(4-methoxyphenyl)sulfonyl-pyrrolidine-2-carboxamide |
|
| NS2 | 表記: | [(2~{S})-2-(6-chloranyl-7-methyl-1~{H}-benzimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-[5-methoxy-2-(1,2,3-triazol-2-yl)phenyl]methanone | 組成式: | C23 H23 Cl N6 O2 | SMILES: | COc1ccc(n2nccn2)c(c1)C(=O)N3CCC[C]3(C)c4[nH]c5c(C)c(Cl)ccc5n4 | InChi: | InChI=1S/C23H23ClN6O2/c1-14-17(24)6-7-18-20(14)28-22(27-18)23(2)9-4-12-29(23)21(31)16-13-15(32-3)5-8-19(16)30-25-10-11-26-30/h5-8,10-11,13H,4,9,12H2,1-3H3,(H,27,28)/t23-/m0/s1 | 定義日: | 2019-12-12 | 最終更新日: | 2019-12-27 | 公開日: | 2020-01-01 | 識別子(ID): | [(2~{S})-2-(6-chloranyl-7-methyl-1~{H}-benzimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-[5-methoxy-2-(1,2,3-triazol-2-yl)phenyl]methanone |
|
| NT5 | 表記: | [(2~{R},5~{R})-5-[(5-fluoranylpyridin-2-yl)oxymethyl]-2-methyl-piperidin-1-yl]-(5-methyl-2-pyrimidin-2-yl-phenyl)methanone | 組成式: | C24 H25 F N4 O2 | SMILES: | C[CH]1CC[CH](COc2ccc(F)cn2)CN1C(=O)c3cc(C)ccc3c4ncccn4 | InChi: | InChI=1S/C24H25FN4O2/c1-16-4-8-20(23-26-10-3-11-27-23)21(12-16)24(30)29-14-18(6-5-17(29)2)15-31-22-9-7-19(25)13-28-22/h3-4,7-13,17-18H,5-6,14-15H2,1-2H3/t17-,18-/m1/s1 | 定義日: | 2019-12-12 | 最終更新日: | 2019-12-27 | 公開日: | 2020-01-01 | 識別子(ID): | [(2~{R},5~{R})-5-[(5-fluoranylpyridin-2-yl)oxymethyl]-2-methyl-piperidin-1-yl]-(5-methyl-2-pyrimidin-2-yl-phenyl)methanone |
|
| NVH | 表記: | 2-(5-methylsulfonylpyridin-3-yl)-1,1-bis(oxidanylidene)-4-[[2,4,6-tris(fluoranyl)phenyl]methyl]pyrido[2,3-e][1,2,4]thiadiazin-3-one | 組成式: | C19 H13 F3 N4 O5 S2 | SMILES: | C[S](=O)(=O)c1cncc(c1)N2C(=O)N(Cc3c(F)cc(F)cc3F)c4ncccc4[S]2(=O)=O | InChi: | InChI=1S/C19H13F3N4O5S2/c1-32(28,29)13-7-12(8-23-9-13)26-19(27)25(10-14-15(21)5-11(20)6-16(14)22)18-17(33(26,30)31)3-2-4-24-18/h2-9H,10H2,1H3 | 定義日: | 2019-12-16 | 最終更新日: | 2019-12-27 | 公開日: | 2020-01-01 | 識別子(ID): | 2-(5-methylsulfonylpyridin-3-yl)-1,1-bis(oxidanylidene)-4-[[2,4,6-tris(fluoranyl)phenyl]methyl]pyrido[2,3-e][1,2,4]thiadiazin-3-one |
|
| NVN | 表記: | 1-[6,8-bis(fluoranyl)-2-methyl-quinolin-4-yl]-3-[4-(dimethylamino)phenyl]urea | 組成式: | C19 H18 F2 N4 O | SMILES: | CN(C)c1ccc(NC(=O)Nc2cc(C)nc3c(F)cc(F)cc23)cc1 | InChi: | InChI=1S/C19H18F2N4O/c1-11-8-17(15-9-12(20)10-16(21)18(15)22-11)24-19(26)23-13-4-6-14(7-5-13)25(2)3/h4-10H,1-3H3,(H2,22,23,24,26) | 定義日: | 2019-12-16 | 最終更新日: | 2019-12-27 | 公開日: | 2020-01-01 | 識別子(ID): | 1-[6,8-bis(fluoranyl)-2-methyl-quinolin-4-yl]-3-[4-(dimethylamino)phenyl]urea |
|
| B7O | 表記: | ~{N}-[4-[(4-~{tert}-butylphenyl)carbonylamino]phenyl]-2,3-dihydro-1,4-benzodioxine-6-carboxamide | 組成式: | C26 H26 N2 O4 | SMILES: | CC(C)(C)c1ccc(cc1)C(=O)Nc2ccc(NC(=O)c3ccc4OCCOc4c3)cc2 | InChi: | InChI=1S/C26H26N2O4/c1-26(2,3)19-7-4-17(5-8-19)24(29)27-20-9-11-21(12-10-20)28-25(30)18-6-13-22-23(16-18)32-15-14-31-22/h4-13,16H,14-15H2,1-3H3,(H,27,29)(H,28,30) | 定義日: | 2019-01-18 | 最終更新日: | 2019-12-27 | 公開日: | 2020-01-01 | 識別子(ID): | ~{N}-[4-[(4-~{tert}-butylphenyl)carbonylamino]phenyl]-2,3-dihydro-1,4-benzodioxine-6-carboxamide |
|
| B7U | 表記: | (2S)-2-phenyl-N-[(1R)-1-phenylethyl]propanamide | 組成式: | C17 H19 N O | SMILES: | O=C(C(C)c1ccccc1)NC(C)c2ccccc2 | InChi: | InChI=1S/C17H19NO/c1-13(15-9-5-3-6-10-15)17(19)18-14(2)16-11-7-4-8-12-16/h3-14H,1-2H3,(H,18,19)/t13-,14+/m0/s1 | 定義日: | 2019-01-21 | 最終更新日: | 2019-12-27 | 公開日: | 2020-01-01 | 識別子(ID): | (2S)-2-phenyl-N-[(1R)-1-phenylethyl]propanamide |
|
| H7S | 表記: | (3S)-3-(5-fluoro-1H-indol-3-yl)pyrrolidine-2,5-dione | 組成式: | C12 H9 F N2 O2 | SMILES: | C1(C(NC(=O)C1)=O)c2cnc3c2cc(cc3)F | InChi: | InChI=1S/C12H9FN2O2/c13-6-1-2-10-7(3-6)9(5-14-10)8-4-11(16)15-12(8)17/h1-3,5,8,14H,4H2,(H,15,16,17)/t8-/m0/s1 | 定義日: | 2018-06-13 | 最終更新日: | 2019-12-27 | 公開日: | 2020-01-01 | 識別子(ID): | (3S)-3-(5-fluoro-1H-indol-3-yl)pyrrolidine-2,5-dione |
|
| JAV | 表記: | 4-fluoro-N'-[(3-hydroxyphenyl)sulfonyl]-5-methyl[1,1'-biphenyl]-3-carbohydrazide | 組成式: | C20 H17 F N2 O4 S | SMILES: | c1(cc(ccc1)O)S(NNC(c2cc(cc(C)c2F)c3ccccc3)=O)(=O)=O | InChi: | InChI=1S/C20H17FN2O4S/c1-13-10-15(14-6-3-2-4-7-14)11-18(19(13)21)20(25)22-23-28(26,27)17-9-5-8-16(24)12-17/h2-12,23-24H,1H3,(H,22,25) | 定義日: | 2018-08-28 | 最終更新日: | 2019-12-20 | 公開日: | 2019-12-25 | 識別子(ID): | 4-fluoro-N'-[(3-hydroxyphenyl)sulfonyl]-5-methyl[1,1'-biphenyl]-3-carbohydrazide |
|
| L3E | 表記: | 4-[(~{E})-[3-[2-chloranyl-6-(trifluoromethyl)phenyl]-5-(1~{H}-pyrrol-3-yl)-1,2-oxazol-4-yl]methylideneamino]benzoic acid | 組成式: | C22 H13 Cl F3 N3 O3 | SMILES: | OC(=O)c1ccc(cc1)N=Cc2c(onc2c3c(Cl)cccc3C(F)(F)F)c4c[nH]cc4 | InChi: | InChI=1S/C22H13ClF3N3O3/c23-17-3-1-2-16(22(24,25)26)18(17)19-15(20(32-29-19)13-8-9-27-10-13)11-28-14-6-4-12(5-7-14)21(30)31/h1-11,27H,(H,30,31)/b28-11+ | 定義日: | 2019-07-17 | 最終更新日: | 2019-12-20 | 公開日: | 2019-12-25 | 識別子(ID): | 4-[(~{E})-[3-[2-chloranyl-6-(trifluoromethyl)phenyl]-5-(1~{H}-pyrrol-3-yl)-1,2-oxazol-4-yl]methylideneamino]benzoic acid |
|
| XJ2 | 表記: | (2R)-1-(methylamino)-3-(1,3,4,5-tetrahydro-2-benzazepin-2-yl)propan-2-ol | 組成式: | C14 H22 N2 O | SMILES: | CNC[CH](O)CN1CCCc2ccccc2C1 | InChi: | InChI=1S/C14H22N2O/c1-15-9-14(17)11-16-8-4-7-12-5-2-3-6-13(12)10-16/h2-3,5-6,14-15,17H,4,7-11H2,1H3/t14-/m1/s1 | 定義日: | 2019-01-10 | 最終更新日: | 2019-12-20 | 公開日: | 2019-12-25 | 識別子(ID): | (2~{R})-1-(methylamino)-3-(1,3,4,5-tetrahydro-2-benzazepin-2-yl)propan-2-ol |
|
| JVZ | 表記: | (2~{S})-1-(benzimidazol-1-yl)-3-(2,3-dihydro-1~{H}-inden-5-yloxy)propan-2-ol | 組成式: | C19 H20 N2 O2 | SMILES: | O[CH](COc1ccc2CCCc2c1)Cn3cnc4ccccc34 | InChi: | InChI=1S/C19H20N2O2/c22-16(11-21-13-20-18-6-1-2-7-19(18)21)12-23-17-9-8-14-4-3-5-15(14)10-17/h1-2,6-10,13,16,22H,3-5,11-12H2/t16-/m0/s1 | 定義日: | 2019-04-05 | 最終更新日: | 2019-12-20 | 公開日: | 2019-12-25 | 識別子(ID): | (2~{S})-1-(benzimidazol-1-yl)-3-(2,3-dihydro-1~{H}-inden-5-yloxy)propan-2-ol |
|
| OZG | 表記: | [6-(3-methoxyphenoxy)-1-benzofuran-3-yl]acetic acid | 組成式: | C17 H14 O5 | SMILES: | c2c(cc1c(c(CC(O)=O)co1)c2)Oc3cc(OC)ccc3 | InChi: | InChI=1S/C17H14O5/c1-20-12-3-2-4-13(8-12)22-14-5-6-15-11(7-17(18)19)10-21-16(15)9-14/h2-6,8-10H,7H2,1H3,(H,18,19) | 定義日: | 2019-07-22 | 最終更新日: | 2019-12-20 | 公開日: | 2019-12-25 | 識別子(ID): | [6-(3-methoxyphenoxy)-1-benzofuran-3-yl]acetic acid |
|
| OZM | 表記: | (6-benzyl-1-benzofuran-3-yl)acetic acid | 組成式: | C17 H14 O3 | SMILES: | C(c1ccc2c(CC(O)=O)coc2c1)c3ccccc3 | InChi: | InChI=1S/C17H14O3/c18-17(19)10-14-11-20-16-9-13(6-7-15(14)16)8-12-4-2-1-3-5-12/h1-7,9,11H,8,10H2,(H,18,19) | 定義日: | 2019-07-22 | 最終更新日: | 2019-12-20 | 公開日: | 2019-12-25 | 識別子(ID): | (6-benzyl-1-benzofuran-3-yl)acetic acid |
|
| M0M | 表記: | (8S)-1,3-dimethyl-8-{[2-(morpholin-4-yl)ethyl]sulfanyl}-6-sulfanylidene-1,3,6,7,8,9-hexahydro-2H-purin-2-one | 組成式: | C13 H21 N5 O2 S2 | SMILES: | C1COCCN1CCSC3NC2=C(C(N(C(=O)N2C)C)=S)N3 | InChi: | InChI=1S/C13H21N5O2S2/c1-16-10-9(11(21)17(2)13(16)19)14-12(15-10)22-8-5-18-3-6-20-7-4-18/h12,14-15H,3-8H2,1-2H3/t12-/m0/s1 | 定義日: | 2019-03-18 | 最終更新日: | 2019-12-20 | 公開日: | 2019-12-25 | 識別子(ID): | (8S)-1,3-dimethyl-8-{[2-(morpholin-4-yl)ethyl]sulfanyl}-6-sulfanylidene-1,3,6,7,8,9-hexahydro-2H-purin-2-one |
|
| M0P | 表記: | 1,3-dimethyl-8-{[2-(morpholin-4-yl)ethyl]sulfanyl}-3,7-dihydro-1H-purine-2,6-dione | 組成式: | C13 H19 N5 O3 S | SMILES: | C1COCCN1CCSc3nc2c(C(N(C(N2C)=O)C)=O)n3 | InChi: | InChI=1S/C13H19N5O3S/c1-16-10-9(11(19)17(2)13(16)20)14-12(15-10)22-8-5-18-3-6-21-7-4-18/h3-8H2,1-2H3,(H,14,15) | 定義日: | 2019-03-18 | 最終更新日: | 2019-12-20 | 公開日: | 2019-12-25 | 識別子(ID): | 1,3-dimethyl-8-{[2-(morpholin-4-yl)ethyl]sulfanyl}-3,7-dihydro-1H-purine-2,6-dione |
|
| M0S | 表記: | 1,3-dimethyl-8-{[2-(pyrrolidin-1-yl)ethyl]sulfanyl}-6-sulfanylidene-1,3,6,9-tetrahydro-2H-purin-2-one | 組成式: | C13 H19 N5 O S2 | SMILES: | c12C(N(C(=O)N(C)c1nc(n2)SCCN3CCCC3)C)=S | InChi: | InChI=1S/C13H19N5OS2/c1-16-10-9(11(20)17(2)13(16)19)14-12(15-10)21-8-7-18-5-3-4-6-18/h3-8H2,1-2H3,(H,14,15) | 定義日: | 2019-03-18 | 最終更新日: | 2019-12-20 | 公開日: | 2019-12-25 | 識別子(ID): | 1,3-dimethyl-8-{[2-(pyrrolidin-1-yl)ethyl]sulfanyl}-6-sulfanylidene-1,3,6,9-tetrahydro-2H-purin-2-one |
|
| M0V | 表記: | 7-[(2S)-2-hydroxy-3-(morpholin-4-yl)propyl]-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione | 組成式: | C14 H21 N5 O4 | SMILES: | O=C2N(C)C(=O)c3n(CC(O)CN1CCOCC1)cnc3N2C | InChi: | InChI=1S/C14H21N5O4/c1-16-12-11(13(21)17(2)14(16)22)19(9-15-12)8-10(20)7-18-3-5-23-6-4-18/h9-10,20H,3-8H2,1-2H3/t10-/m0/s1 | 定義日: | 2019-03-18 | 最終更新日: | 2019-12-20 | 公開日: | 2019-12-25 | 識別子(ID): | 7-[(2S)-2-hydroxy-3-(morpholin-4-yl)propyl]-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione |
|
| M1D | 表記: | 4-(1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-7H-purin-7-yl)butanoic acid | 組成式: | C11 H14 N4 O4 | SMILES: | O=C1N(C(=O)c2c(N1C)ncn2CCCC(O)=O)C | InChi: | InChI=1S/C11H14N4O4/c1-13-9-8(10(18)14(2)11(13)19)15(6-12-9)5-3-4-7(16)17/h6H,3-5H2,1-2H3,(H,16,17) | 定義日: | 2019-03-18 | 最終更新日: | 2019-12-20 | 公開日: | 2019-12-25 | 識別子(ID): | 4-(1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-7H-purin-7-yl)butanoic acid |
|
| M3B | 表記: | (1~{S})-~{N}'-(4-azanylbutyl)-~{N}"-(2-methoxyethyl)methanetriamine | 組成式: | C8 H22 N4 O | SMILES: | COCCN[CH](N)NCCCCN | InChi: | InChI=1S/C8H22N4O/c1-13-7-6-12-8(10)11-5-3-2-4-9/h8,11-12H,2-7,9-10H2,1H3/t8-/m0/s1 | 定義日: | 2019-10-02 | 最終更新日: | 2019-12-20 | 公開日: | 2019-12-25 | 識別子(ID): | (1~{S})-~{N}'-(4-azanylbutyl)-~{N}"-(2-methoxyethyl)methanetriamine |
|
| QEV | 表記: | methyl [(3R,7S)-7-{[1-(3-chloro-2-fluorophenyl)-5-methyl-1H-imidazole-4-carbonyl]amino}-3-methyl-2-oxo-2,3,4,5,6,7-hexahydro-1H-12,8-(metheno)-1,9-benzodiazacyclotetradecin-15-yl]carbamate | 組成式: | C31 H30 Cl F N6 O4 | SMILES: | C2(C(CCCC(c3cc(c1c(cc(cc1)NC(OC)=O)N2)ccn3)NC(=O)c5c(n(c4c(c(Cl)ccc4)F)cn5)C)C)=O | InChi: | InChI=1S/C31H30ClFN6O4/c1-17-6-4-8-23(37-30(41)28-18(2)39(16-35-28)26-9-5-7-22(32)27(26)33)25-14-19(12-13-34-25)21-11-10-20(36-31(42)43-3)15-24(21)38-29(17)40/h5,7,9-17,23H,4,6,8H2,1-3H3,(H,36,42)(H,37,41)(H,38,40)/t17-,23+/m1/s1 | 定義日: | 2019-10-18 | 最終更新日: | 2019-12-20 | 公開日: | 2019-12-25 | 識別子(ID): | methyl [(3R,7S)-7-{[1-(3-chloro-2-fluorophenyl)-5-methyl-1H-imidazole-4-carbonyl]amino}-3-methyl-2-oxo-2,3,4,5,6,7-hexahydro-1H-12,8-(metheno)-1,9-benzodiazacyclotetradecin-15-yl]carbamate |
|
| QEY | 表記: | methyl [(3R,7S)-7-{[5-amino-1-(3-chloro-2-fluorophenyl)-1H-pyrazole-4-carbonyl]amino}-3-methyl-2-oxo-2,3,4,5,6,7-hexahydro-1H-12,8-(metheno)-1,9-benzodiazacyclotetradecin-15-yl]carbamate | 組成式: | C30 H29 Cl F N7 O4 | SMILES: | C2(C(CCCC(c3cc(c1c(cc(cc1)NC(OC)=O)N2)ccn3)NC(=O)c5c(n(c4c(c(Cl)ccc4)F)nc5)N)C)=O | InChi: | InChI=1S/C30H29ClFN7O4/c1-16-5-3-7-22(37-29(41)20-15-35-39(27(20)33)25-8-4-6-21(31)26(25)32)24-13-17(11-12-34-24)19-10-9-18(36-30(42)43-2)14-23(19)38-28(16)40/h4,6,8-16,22H,3,5,7,33H2,1-2H3,(H,36,42)(H,37,41)(H,38,40)/t16-,22+/m1/s1 | 定義日: | 2019-10-18 | 最終更新日: | 2019-12-20 | 公開日: | 2019-12-25 | 識別子(ID): | methyl [(3R,7S)-7-{[5-amino-1-(3-chloro-2-fluorophenyl)-1H-pyrazole-4-carbonyl]amino}-3-methyl-2-oxo-2,3,4,5,6,7-hexahydro-1H-12,8-(metheno)-1,9-benzodiazacyclotetradecin-15-yl]carbamate |
|
| QNL | 表記: | ~{N}-[2-methanoyl-4-(2-methylpropoxy)quinolin-8-yl]ethanamide | 組成式: | C16 H18 N2 O3 | SMILES: | CC(C)COc1cc(C=O)nc2c(NC(C)=O)cccc12 | InChi: | InChI=1S/C16H18N2O3/c1-10(2)9-21-15-7-12(8-19)18-16-13(15)5-4-6-14(16)17-11(3)20/h4-8,10H,9H2,1-3H3,(H,17,20) | 定義日: | 2018-12-04 | 最終更新日: | 2019-12-20 | 公開日: | 2019-12-25 | 識別子(ID): | ~{N}-[2-methanoyl-4-(2-methylpropoxy)quinolin-8-yl]ethanamide |
|